Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Inv. presentation
Quarterly results
|
|
Achaogen Inc (AKAO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/06/2019 |
GN
| Achaogen, Inc. Announces Results of Auction for Substantially All Company Assets |
| 04/15/2019 |
GN
| Achaogen Plans for Near-Term Sale Using Structured Process Through Chapter 11 of the U.S. Bankruptcy Code |
| 03/28/2019 |
GN
| Achaogen Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update |
| 02/20/2019 |
GN
| Achaogen Announces Closing of $15 Million Underwritten Public Offering |
| 02/20/2019 |
GN
| Achaogen Announces Presentations at Two Upcoming Investor Healthcare Conferences |
| 02/15/2019 |
GN
| Achaogen Announces Pricing of $15 Million Underwritten Public Offering |
| 02/14/2019 |
GN
| Achaogen Submits Response to ASPR/BARDA Request for Information (RFI) for Antimicrobial Resistance Project BioShield |
| 02/14/2019 |
GN
| Achaogen Provides Update on Corporate Progress and Key Preliminary Fourth Quarter 2018 Results |
| 12/10/2018 |
GN
| Achaogen Announces FDA Clearance and Launch of the Thermo Scientific QMS Plazomicin Immunoassay |
| 11/26/2018 |
GN
| Achaogen Announces Multiple Plazomicin Presentations at the American Society of Health Systems Pharmacists (ASHP) Midyear Clinical Meeting |
| 11/09/2018 |
GN
| Achaogen Announces Presentations at Two Investor Healthcare Conferences in November |
| 11/08/2018 |
GN
| Achaogen Reports Third Quarter 2018 Financial Results and Provides Corporate Update |
| 11/05/2018 |
GN
| Achaogen Announces Review of Strategic Alternatives and Corporate Restructuring |
| 11/02/2018 |
GN
| Achaogen to Host Conference Call and Webcast of Third Quarter 2018 Financial Results on November 8, 2018 |
| 10/17/2018 |
GN
| Achaogen Submits Marketing Authorization Application to the European Medicines Agency for Plazomicin |
| 10/03/2018 |
GN
| Achaogen Highlights Multiple Plazomicin Presentations at IDWeek 2018 |
| 09/19/2018 |
GN
| Achaogen Announces Multiple Plazomicin Presentations at IDWeek 2018 |
| 09/18/2018 |
GN
| Achaogen to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference |
| 09/04/2018 |
GN
| Achaogen Highlights Multiple Plazomicin Presentations at ESCMID/ASM 2018 Conference |
| 08/15/2018 |
GN
| Analysis: Positioning to Benefit within Northeast, Hurco Companies, PGT, Bassett Furniture Industries, Insys Therapeutics, and Achaogen — Research Highlights Growth, Revenue, and Consolidated Results |
| 07/24/2018 |
GN
| Achaogen to Host Conference Call and Webcast of Second Quarter 2018 Financial Results on August 6, 2018 |
| 07/20/2018 |
GN
| Achaogen Launches ZEMDRI™ (plazomicin), a Once-Daily Aminoglycoside for use in complicated Urinary Tract Infections (cUTI) |
| 07/10/2018 |
GN
| Achaogen to Host Investor Lunch Updating Investors on Commercial Strategy Post FDA Approval of Plazomicin on July 12th in New York City |
| 06/26/2018 |
GN
| UPDATE -- ZEMDRI™ (plazomicin) Approved by FDA for the Treatment of Adults with Complicated Urinary Tract Infections (cUTI) |
| 06/26/2018 |
GN
| ZEMDRITM (plazomicin) Approved by FDA for the Treatment of Adults with Complicated Urinary Tract Infections (cUTI) |
| 06/11/2018 |
GN
| Achaogen Highlights Multiple Plazomicin Presentations at ASM Microbe 2018 Annual Meeting |
| 05/24/2018 |
GN
| Achaogen Announces Multiple Plazomicin Presentations at ASM Microbe 2018 Annual Meeting |
| 05/04/2018 |
GN
| Achaogen Reports First Quarter 2018 Financial Results and Provides Corporate Update |
| 05/02/2018 |
GN
| Achaogen Announces FDA Advisory Committee Voted Unanimously in Favor of Plazomicin for Treatment of Adults with Complicated Urinary Tract Infections |
| 05/02/2018 |
GN
| Achaogen Stock Trading Halted Today |
| 04/26/2018 |
GN
| Achaogen Wins CARB-X Funding Award to Advance Development of Novel Aminoglycoside to Fight Highly-Resistant Infections |
| 04/25/2018 |
GN
| Achaogen to Host Conference Call and Webcast of First Quarter 2018 Financial Results on May 4, 2018 |
| 04/23/2018 |
GN
| Achaogen Highlights Plazomicin Presentations at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) |
| 04/10/2018 |
GN
| Achaogen Announces Multiple Plazomicin Presentations at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) |
|
|
|